Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Tralokinumab for severe, uncontrolled asthma (STRATOS 1 and STRATOS 2): two randomised, double-blind, placebo-controlled, phase 3 clinical trials.

Panettieri RA Jr, Sjöbring U, Péterffy A, Wessman P, Bowen K, Piper E, Colice G, Brightling CE.

Lancet Respir Med. 2018 Jul;6(7):511-525. doi: 10.1016/S2213-2600(18)30184-X. Epub 2018 May 20.

PMID:
29792288
2.

Transient paradoxical bronchospasm associated with inhalation of the LAMA AZD9164: analysis of two Phase I, randomised, double-blind, placebo-controlled studies.

Jorup C, Bengtsson T, Strandgården K, Sjöbring U.

BMC Pulm Med. 2014 Mar 27;14:52. doi: 10.1186/1471-2466-14-52.

3.

Effect of different asthma treatments on risk of cold-related exacerbations.

Reddel HK, Jenkins C, Quirce S, Sears MR, Bateman ED, O'Byrne PM, Humbert M, Buhl R, Harrison T, Brusselle GG, Thorén A, Sjöbring U, Peterson S, Ostlund O, Eriksson GS.

Eur Respir J. 2011 Sep;38(3):584-93. doi: 10.1183/09031936.00186510. Epub 2011 Mar 15. Erratum in: Eur Respir J. 2012 May;39(5):1280.

4.

Injury is a major inducer of epidermal innate immune responses during wound healing.

Roupé KM, Nybo M, Sjöbring U, Alberius P, Schmidtchen A, Sørensen OE.

J Invest Dermatol. 2010 Apr;130(4):1167-77. doi: 10.1038/jid.2009.284. Epub 2009 Sep 3. Erratum in: J Invest Dermatol. 2010 Mar;130(3):910.

5.

Budesonide and the risk of pneumonia: a meta-analysis of individual patient data.

Sin DD, Tashkin D, Zhang X, Radner F, Sjöbring U, Thorén A, Calverley PM, Rennard SI.

Lancet. 2009 Aug 29;374(9691):712-9. doi: 10.1016/S0140-6736(09)61250-2.

PMID:
19716963
6.

Allelic variants of streptokinase from Streptococcus pyogenes display functional differences in plasminogen activation.

McArthur JD, McKay FC, Ramachandran V, Shyam P, Cork AJ, Sanderson-Smith ML, Cole JN, Ringdahl U, Sjöbring U, Ranson M, Walker MJ.

FASEB J. 2008 Sep;22(9):3146-53. doi: 10.1096/fj.08-109348. Epub 2008 May 29.

PMID:
18511548
7.

Lipopolysaccharide challenge of humans as a model for chronic obstructive lung disease exacerbations.

Kharitonov SA, Sjöbring U.

Contrib Microbiol. 2007;14:83-100. doi: 10.1159/000107056. Review.

PMID:
17684334
8.

Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation.

Shannon O, Hertzén E, Norrby-Teglund A, Mörgelin M, Sjöbring U, Björck L.

Mol Microbiol. 2007 Sep;65(5):1147-57. Epub 2007 Jul 27.

9.

Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor.

Sørensen OE, Thapa DR, Roupé KM, Valore EV, Sjöbring U, Roberts AA, Schmidtchen A, Ganz T.

J Clin Invest. 2006 Jul;116(7):1878-85. Epub 2006 Jun 15.

10.

Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators.

Nilsson M, Sørensen OE, Mörgelin M, Weineisen M, Sjöbring U, Herwald H.

Thromb Haemost. 2006 Jun;95(6):982-90.

PMID:
16732377
11.
12.

Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.

Sun H, Ringdahl U, Homeister JW, Fay WP, Engleberg NC, Yang AY, Rozek LS, Wang X, Sjöbring U, Ginsburg D.

Science. 2004 Aug 27;305(5688):1283-6.

13.
14.

Contributions of amino acid side chains to the kinetics and thermodynamics of the bivalent binding of protein L to Ig kappa light chain.

Svensson HG, Wedemeyer WJ, Ekstrom JL, Callender DR, Kortemme T, Kim DE, Sjöbring U, Baker D.

Biochemistry. 2004 Mar 9;43(9):2445-57.

PMID:
14992582
15.
16.

Roles of the plasminogen activator streptokinase and the plasminogen-associated M protein in an experimental model for streptococcal impetigo.

Svensson MD, Sjöbring U, Luo F, Bessen DE.

Microbiology. 2002 Dec;148(Pt 12):3933-3945. doi: 10.1099/00221287-148-12-3933.

PMID:
12480897
17.

EndoS and SpeB from Streptococcus pyogenes inhibit immunoglobulin-mediated opsonophagocytosis.

Collin M, Svensson MD, Sjöholm AG, Jensenius JC, Sjöbring U, Olsén A.

Infect Immun. 2002 Dec;70(12):6646-51.

18.

Induction of platelet thrombi by bacteria and antibodies.

Sjöbring U, Ringdahl U, Ruggeri ZM.

Blood. 2002 Dec 15;100(13):4470-7. Epub 2002 Aug 1.

PMID:
12393652
19.

Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H-like protein 1 binding.

Kotarsky H, Gustafsson M, Svensson HG, Zipfel PF, Truedsson L, Sjöbring U.

Mol Microbiol. 2001 Aug;41(4):817-26.

20.

Staphylococcus aureus induces release of bradykinin in human plasma.

Mattsson E, Herwald H, Cramer H, Persson K, Sjöbring U, Björck L.

Infect Immun. 2001 Jun;69(6):3877-82.

21.

Zinc-dependent conformational changes in domain D5 of high molecular mass kininogen modulate contact activation.

Herwald H, Mörgelin M, Svensson HG, Sjöbring U.

Eur J Biochem. 2001 Jan;268(2):396-404.

22.

Role for a secreted cysteine proteinase in the establishment of host tissue tropism by group A streptococci.

Svensson MD, Scaramuzzino DA, Sjöbring U, Olsén A, Frank C, Bessen DE.

Mol Microbiol. 2000 Oct;38(2):242-53.

23.

A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance.

Ringdahl U, Svensson HG, Kotarsky H, Gustafsson M, Weineisen M, Sjöbring U.

Mol Microbiol. 2000 Sep;37(6):1318-26.

24.

Analysis of plasminogen-binding M proteins of Streptococcus pyogenes.

Ringdahl U, Sjöbring U.

Methods. 2000 Jun;21(2):143-50.

PMID:
10816375
25.

Human complement regulators: a major target for pathogenic microorganisms.

Lindahl G, Sjöbring U, Johnsson E.

Curr Opin Immunol. 2000 Feb;12(1):44-51. Review.

PMID:
10679403
26.

Strain-specific restriction of the antiphagocytic property of group A streptococcal M proteins.

Kotarsky H, Thern A, Lindahl G, Sjöbring U.

Infect Immun. 2000 Jan;68(1):107-12.

27.
28.

Protein LA, a novel hybrid protein with unique single-chain Fv antibody- and Fab-binding properties.

Svensson HG, Hoogenboom HR, Sjöbring U.

Eur J Biochem. 1998 Dec 1;258(2):890-6.

29.

Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.

Johnsson E, Berggård K, Kotarsky H, Hellwage J, Zipfel PF, Sjöbring U, Lindahl G.

J Immunol. 1998 Nov 1;161(9):4894-901.

30.

Kringle 2 mediates high affinity binding of plasminogen to an internal sequence in streptococcal surface protein PAM.

Wistedt AC, Kotarsky H, Marti D, Ringdahl U, Castellino FJ, Schaller J, Sjöbring U.

J Biol Chem. 1998 Sep 18;273(38):24420-4.

31.

Molecular co-operation between protein PAM and streptokinase for plasmin acquisition by Streptococcus pyogenes.

Ringdahl U, Svensson M, Wistedt AC, Renné T, Kellner R, Müller-Esterl W, Sjöbring U.

J Biol Chem. 1998 Mar 13;273(11):6424-30.

32.

Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins.

Kotarsky H, Hellwage J, Johnsson E, Skerka C, Svensson HG, Lindahl G, Sjöbring U, Zipfel PF.

J Immunol. 1998 Apr 1;160(7):3349-54.

33.

Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin.

Ben Nasr A, Herwald H, Sjöbring U, Renné T, Müller-Esterl W, Björck L.

Biochem J. 1997 Sep 15;326 ( Pt 3):657-60.

34.

NMR analysis of the interaction between protein L and Ig light chains.

Enokizono J, Wikström M, Sjöbring U, Björck L, Forsén S, Arata Y, Kato K, Shimada I.

J Mol Biol. 1997 Jul 4;270(1):8-13.

PMID:
9231896
35.

Characterization of the binding properties of protein LG, an immunoglobulin-binding hybrid protein.

Kihlberg BM, Sjöholm AG, Björck L, Sjöbring U.

Eur J Biochem. 1996 Sep 15;240(3):556-63.

36.

Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli.

Ben Nasr A, Olsén A, Sjöbring U, Müller-Esterl W, Björck L.

Mol Microbiol. 1996 Jun;20(5):927-35.

PMID:
8809746
37.

Identification of a plasminogen-binding motif in PAM, a bacterial surface protein.

Wistedt AC, Ringdahl U, Müller-Esterl W, Sjøbring U.

Mol Microbiol. 1995 Nov;18(3):569-78.

PMID:
8748039
38.
39.

Mapping of the immunoglobulin light chain-binding site of protein L.

Wikström M, Sjöbring U, Drakenberg T, Forsén S, Björck L.

J Mol Biol. 1995 Jul 7;250(2):128-33. Erratum in: J Mol Biol 1996 Mar 15;256(5):949.

PMID:
7608965
40.

[PCR in the diagnosis of tuberculosis. A rapid, sensitive and specific technique].

Sjöbring U, Olsson B, Rånby M, Miörner H.

Lakartidningen. 1995 Apr 19;92(16):1683-5. Swedish. No abstract available.

PMID:
7723482
41.

Three-dimensional solution structure of an immunoglobulin light chain-binding domain of protein L. Comparison with the IgG-binding domains of protein G.

Wikström M, Drakenberg T, Forsén S, Sjöbring U, Björck L.

Biochemistry. 1994 Nov 29;33(47):14011-7.

PMID:
7947810
43.

Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins.

Ben Nasr A, Wistedt A, Ringdahl U, Sjöbring U.

Eur J Biochem. 1994 Jun 1;222(2):267-76.

44.

Protein H--a surface protein of Streptococcus pyogenes with separate binding sites for IgG and albumin.

Frick IM, Akesson P, Cooney J, Sjöbring U, Schmidt KH, Gomi H, Hattori S, Tagawa C, Kishimoto F, Björck L.

Mol Microbiol. 1994 Apr;12(1):143-51.

PMID:
8057834
45.

PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.

Berge A, Sjöbring U.

J Biol Chem. 1993 Dec 5;268(34):25417-24.

46.

Proton nuclear magnetic resonance sequential assignments and secondary structure of an immunoglobulin light chain-binding domain of protein L.

Wikström M, Sjöbring U, Kastern W, Björck L, Drakenberg T, Forsén S.

Biochemistry. 1993 Apr 6;32(13):3381-6.

PMID:
8461301
47.

Protein LG: a hybrid molecule with unique immunoglobulin binding properties.

Kihlberg BM, Sjöbring U, Kastern W, Björck L.

J Biol Chem. 1992 Dec 15;267(35):25583-8.

48.
49.

Convergent evolution among immunoglobulin G-binding bacterial proteins.

Frick IM, Wikström M, Forsén S, Drakenberg T, Gomi H, Sjöbring U, Björck L.

Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8532-6.

Supplemental Content

Loading ...
Support Center